Abstract
The utility of longitudinal AST-To-platelet ratio index (APRI), a surrogate for hepatic fibrosis, is unknown.We compared APRI up to 9 years before liver-related death among 57 cases of viral hepatitis-infected men (91% HIVR) to matched controls. APRI was stable among controls but, among cases, increased 4.6%/year from 9 to 3 years predeath (PU0.10) and 30%/year during the 3 years predeath (P0.001). Thus, rapid APRI increase may predict impending liver-related death in HIV-viral hepatitis coinfection.
Original language | English (US) |
---|---|
Pages (from-to) | 2636-2638 |
Number of pages | 3 |
Journal | AIDS |
Volume | 32 |
Issue number | 17 |
DOIs | |
State | Published - 2018 |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Infectious Diseases